GGrantIndex
← Leaderboards

Gerard C Grosveld

St. Jude Children'S Research Hospital

$6,988,770
Attributed
$6,988,770
Total exposure
5
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $638.3K · FY200513
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$6,988,770 · 5

By mechanism

R01$4,315,666 · 2
P30$1,509,735 · 1
P01$1,163,369 · 2

Top collaborators

No co-investigators on record.

Most similar at St. Jude Children'S Research Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Laboratory Mouse

Research focus

Laboratory MouseGenetically Modified AnimalsTranscription FactorChimeric ProteinsGenesGene TargetingCarcinogenesisLeukemiaNeoplasm /Cancer GeneticsBiomedical FacilityGene ExpressionAnimal ColonyIn VivoKnockout GeneComplementary DnaInjection Of Therapeutic AgentMutateCancer CenterGene FunctionAnimal ModelGene MutationEmbryonic Stem CellCell GrowthMalignant Neoplasms

Grant awards (29)

Transgenic Gene Knockout$802
P30 · FY2013 · CA · contact PI
Transgenic Gene Knockout$253,079
P30 · FY2012 · CA · contact PI
Transgenic Gene Knockout$284,797
P30 · FY2011 · CA · contact PI
Role of MN1-TEL and MN1 in Leukemogenesis$333,189
R01 · FY2010 · CA · contact PI
Transgenic Gene Knockout$305,157
P30 · FY2010 · CA · contact PI
Role of MN1-TEL and MN1 in Leukemogenesis$333,189
R01 · FY2009 · CA · contact PI
Transgenic Gene Knockout$297,952
P30 · FY2009 · CA · contact PI
Role of MN1-TEL and MN1 in Leukemogenesis$333,189
R01 · FY2008 · CA · contact PI
Transgenic Gene Knockout$163,678
P30 · FY2008 · CA · contact PI
Role of MN1-TEL and MN1 in Leukemogenesis$327,240
R01 · FY2007 · CA · contact PI
Role of MN1-TEL and MN1 in Leukemogenesis$330,885
R01 · FY2006 · CA · contact PI
Role of MN1 TEL and TEL in Leukemogenesis$311,250
R01 · FY2005 · CA
Role of MN1 TEL and TEL in Leukemogenesis$311,250
R01 · FY2004 · CA
Role of MN1 TEL and TEL in Leukemogenesis$311,250
R01 · FY2003 · CA
Role of MN1 TEL and TEL in Leukemogenesis$311,250
R01 · FY2002 · CA
DEK EFFECTS ON GROWTH OF HEMATOPOIETIC CELLS$303,281
R01 · FY2002 · CA
CORE--TRANSGENIC AND GENE DISRUPTION LABORATORY$241,412
P01 · FY2002 · CA
PAX3/FKHR IN ALVEOLAR RHABDOMYOSARCOMA$241,412
P01 · FY2002 · CA
CORE--TRANSGENIC/GENE KNOCKOUT SHARED RESOURCE$0
P30 · FY2002 · CA
CORE--TRANSGENIC/GENE KNOCKOUT$0
P30 · FY2002 · CA
Role of MN1 TEL and TEL in Leukemogenesis$309,175
R01 · FY2001 · CA
DEK EFFECTS ON GROWTH OF HEMATOPOIETIC CELLS$288,636
R01 · FY2001 · CA
CORE--TRANSGENIC AND GENE DISRUPTION LABORATORY$241,412
P01 · FY2001 · CA
PAX3/FKHR IN ALVEOLAR RHABDOMYOSARCOMA$241,412
P01 · FY2001 · CA
CORE--TRANSGENIC/GENE KNOCKOUT SHARED RESOURCE$0
P30 · FY2001 · CA
DEK EFFECTS ON GROWTH OF HEMATOPOIETIC CELLS$288,636
R01 · FY2000 · CA
MN1 TEL AND TEL AND LEUKEMOGENESIS$223,246
R01 · FY2000 · CA
CORE--TRANSGENIC/GENE KNOCKOUT SHARED RESOURCE$204,270
P30 · FY2000 · CA
CORE--TRANSGENES AND GENE DISRUPTION IN MURINE MODELS$197,721
P01 · FY2000 · CA